Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies

Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies

US Patent 9631025 · Granted Apr 25, 2017

Estimated economic value: $685,095,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Niclosamide formulations and methods of use2025
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Niclosamide formulations and methods of use2024
Niclosamide formulations and methods of use2023
Large scale purification of castanospermine2022
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2022
Treatment of human coronavirus infections using alpha-glucosidase glycoprotein p2022
Human monoclonal antibodies that bind CXCR4 and uses thereof2022
Human monoclonal antibodies that bind CXCR4 and uses thereof2022
Treatment of C1013G/CXCR4-associated Waldenstrom's macroglobulinemia with an ant2022
Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibod2021
Interferon receptor 1 antibodies and their uses2021